Abbott LaboratoriesABTNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-16.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-16.4%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 11.78% |
| 2024 | 17.86% |
| 2023 | -24.21% |
| 2022 | -9.04% |
| 2021 | 33.31% |
| 2020 | 28.76% |
| 2019 | -2.60% |
| 2018 | 13.11% |
| 2017 | 73.90% |
| 2016 | 7.99% |